HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Edward P. Chen Kenichi A. Tanaka Permission Requests Google Scholar Articles by Bolliger, D. Articles by Tanaka, K. A. PubMed Articles by Bolliger, D. Articles by Tanaka, K. A. Related Collections Extracorporeal circulation

---

Case Reports

Prophylactic Use of Factor IX Concentrate in a Jehovah's Witness Patient

^a Department of Anesthesiology, Emory University School of Medicine, Atlanta, Georgia
^b Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia
^c Department of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia

Accepted for publication March 25, 2009.

^_* Address correspondence to Dr Tanaka, Department of Anesthesiology, Emory University, School of Medicine, 1364 Clifton Rd, NE, Atlanta, GA 30322 (Email: ktanaka{at}emory.edu).

In Jehovah's Witness patients, the use of red blood cells, platelets, and fresh frozen plasma is not optional. Various blood conservation techniques are available, but complex cardiac surgery remains a major challenge. The feasibility of fractions of "primary components" has not been fully considered in published case reports. For Jehovah's Witness patients who preoperatively give consent, factor IX concentrates may be acceptable for hemostatic therapy. We hereby describe a combination of "secondary components" to prevent excessive bleeding in a Jehovah's Witness patient undergoing complex replacement of the aortic arch.